JON D KAISER, M.D.
Medical Practice in Mill Valley, CA

2005014, Jun 30, 2005

Dec 31, 2003

10/750545

Jon Kaiser - Mill Valley CA, US

A61K038/43, A61K038/05, A61K031/198, A61K031/353, A61K031/375

424094100, 514018000, 514440000, 514546000, 514562000, 424641000, 424702000, 514456000, 514458000, 514474000

The invention provides a nutrient composition for augmenting immune strength or physiological detoxification. The nutrient composition consists of an optimal combination of an effective amount of at least one vitamin antioxidant, at least one mineral antioxidant and a highly saturable amount of at least three high potency antioxidants. The at least one vitamin antioxidant can be vitamin C, bioflavonoid complex, vitamin E, vitamin B6 or beta-carotene and the at least one mineral antioxidant can be zinc or selenium. The at least three high potency antioxidants can be alpha lipoic acid, acetyl L-carnitine, N-acetyl-cysteine, co-enzyme Q10 or glutathione. Also provided is a nutrient composition for augmenting immune strength or physiological detoxification that consists of an optimal combination of an effective amount of at least three vitamin antioxidants, at least two mineral antioxidants and a highly saturable amount of at least three high potency antioxidants. Further provided is a method of stimulating immune system function or a method of augmenting a therapeutic treatment of a disease. The method consists of administering to an individual a nutrient composition of the invention one or more times a day over a period of about 5-7 weeks, the immune system function being stimulated to result in an increase of CD4+ cells of at least about 15% compared to pre-administration levels. A method of stimulating a physiological detoxification function of an individual or a method of augmenting a therapeutic treatment of a disease is also provided. The method consists of administering to an individual a nutrient composition of the invention one or more times a day over a period of about 5-7 weeks, the physiological detoxification function being stimulated to result in a decrease of one or more free radical markers by about 20% compared to pre-administration levels.

2008021, Sep 4, 2008

Mar 7, 2008

12/044907

Jon D. Kaiser - Mill Valley CA, US

INTEGRATIVE HEALTH CONSULTING, INC. - Mill Valley CA

A61K 33/30, A61K 31/205, A61K 31/197, A61K 33/00, A61K 31/355, A61K 31/519, A61K 31/07, A61K 31/047, A61K 31/375, A61K 31/385, A61K 31/4415

424641, 514556, 514562, 514440, 514348, 424600, 514474, 514458, 514738, 51425216, 514725

The invention provides a nutrient composition for augmenting immune strength or physiological detoxification. The nutrient composition consists of an optimal combination of an effective amount of at least one vitamin antioxidant, at least one mineral antioxidant and a highly saturable amount of at least three high potency antioxidants. The at least one vitamin antioxidant can be vitamin C, bioflavonoid complex, vitamin E, vitamin B6 or beta-carotene and the at least one mineral antioxidant can be zinc or selenium. The at least three high potency antioxidants can be alpha lipoic acid, acetyl L-carnitine, N-acetyl-cysteine, co-enzyme Q10 or glutathione. Also provided is a nutrient composition for augmenting immune strength or physiological detoxification that consists of an optimal combination of an effective amount of at least three vitamin antioxidants, at least two mineral antioxidants and a highly saturable amount of at least three high potency antioxidants. Further provided is a method of stimulating immune system function or a method of augmenting a therapeutic treatment of a disease. The method consists of administering to an individual a nutrient composition of the invention one or more times a day over a period of about 5-7 weeks, the immune system function being stimulated to result in an increase of CD4+ cells of at least about 15% compared to pre-administration levels. A method of stimulating a physiological detoxification function of an individual or a method of augmenting a therapeutic treatment of a disease is also provided. The method consists of administering to an individual a nutrient composition of the invention one or more times a day over a period of about 5-7 weeks, the physiological detoxification function being stimulated to result in a decrease of one or more free radical markers by about 20% compared to pre-administration levels.

8361512, Jan 29, 2013

May 27, 2011

13/117811

Jon D. Kaiser - Mill Valley CA, US

K-PAX Vitamins, Inc. - Mill Valley CA

A61K 33/32, A61K 33/04, A61K 31/355, A61K 31/34, A61K 31/095, A01N 59/16, A01N 59/02, A01N 43/16, A01N 43/08, A01N 31/00

424600, 424641, 424702, 424703, 514458, 514474, 514706, 514885

Provided are methods and compositions for increasing CD4 cell count in mammals, preferably by at least 25%, while undergoing treatment for various conditions whose treatment can have detrimental effects on immune system function. Such conditions include, but are not limited to, HIV infection, cancer, and hepatitis. The compositions include alpha lipoic acid; acetyl L-carnitine; N-acetyl-cysteine; zinc; selenium; vitamin C; bioflavinoid complex; vitamin E; optionally one or more antioxidants selected from co-enzyme Q10 and glutathione; and one or more vitamins or minerals selected from beta-carotene, vitamin A, vitamin B1, vitamin B2, vitamin B6, niacinamide, calcium pantothenate, folic acid, vitamin B12, copper, manganese, chromium, and molybdenum.

2013009, Apr 11, 2013

Nov 30, 2012

13/690740

Jon D. Kaiser - Mill Valley CA, US

A61K 31/4458, A61K 31/198, A61K 31/205, A61K 31/385, A61K 31/223

514317

Pharmaceutical compositions and methods for the treatment of neuropsychological impairment in human patients comprising a central nervous system (CNS) stimulant in a daily low-dosage amount, and a micronutrient composition containing acetyl L-carnitine, L-tyrosine, N-acetyl cysteine, and alpha-lipoic acid. The CNS stimulant and micronutrient components may be in admixture for convenient daily oral administration of a low dosage CNS stimulant and micronutrients in the range of bout 60-250 mg acetyl L-carnitine, 50-200 mg L-tyrosine, 60-250 mg N-acetyl cystein, and 25-100 mg alpha-lipoic acid per day.

2012032, Dec 27, 2012

Jun 22, 2012

13/530673

Jon D. Kaiser - Mill Valley CA, US

A61K 31/385, A61K 31/4415, A61P 25/00, A61K 9/48, A61K 31/522, A61K 31/4458, A61K 31/714

424451, 514440, 514317, 514345, 514 52, 51426331

Pharmaceutical compositions and methods for the treatment of chronic fatigue in human patients comprising a central nervous system (CNS) stimulant in a daily low-dosage amount in combination with therapeutically effective daily amounts of micronutrients, comprising acetyl L-carnitine, L-tyrosine, N-acetyl cysteine, and alpha-lipoic acid. The CNS and micronutrient components may be in an oral dosage composition containing a low dosage amount of CNS stimulant such as about 2.5 mg methylphenidate HCl together with about 60-250 mg acetyl L-carnitine, 50-200 mg L-tyrosine, 60-250 mg N-acetyl cysteine, and 25-100 mg alpha-lipoic acid.

2013018, Jul 18, 2013

Dec 19, 2012

13/720080

Jon D. Kaiser - Mill Valley CA, US

A61K 33/34, A61K 33/30, A61K 33/04, A61K 31/714, A61K 31/525, A61K 31/51, A61K 33/32, A61K 33/24, A61K 33/26, A61K 31/519, A61K 31/455, A61K 31/122, A61K 31/4188, A61K 31/593, A61K 33/06, A61K 33/18, A61K 33/22, A61K 33/00, A61K 31/7056, A61K 31/7076, A61K 31/195, A61K 45/06, A61K 31/381

424 941, 514440, 424641, 424702, 514 52, 514251, 514276, 424630, 424639, 424655, 424646, 514249, 514354, 514690, 514393, 514167, 424682, 424667, 424657, 424722, 514 50, 514 45

Provided are compositions and methods for increasing patient CD4+ cell count while undergoing treatment for immune-mediated disease, cancer, heart disease, neurodegenerative disease, or infectious disease by administering to the patient a nutrient composition including, inter alia, alpha lipoic acid, acetyl L-carnitine, and N-acetyl-cysteine.